J. P. Quenot, A. Pavon, I. Fournel, S. D. Barbar, and R. Bruyère, Le choc septique de l'adulte en France : vingt ans de données épidémiologiques, Réanimation. 1 mai, vol.24, issue.3, pp.303-312, 2015.

M. Singer, C. S. Deutschman, C. W. Seymour, M. Shankar-hari, D. Annane et al., The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA. 23 févr, vol.315, issue.8, pp.801-811, 2016.

, SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study, Intensive Care Med. 1 déc, vol.42, issue.12, pp.1980-1989, 2016.

A. S. De-la-rica, F. Gilsanz, and E. Maseda, Epidemiologic trends of sepsis in western countries, Ann Transl Med. 13 sept, vol.4, issue.17, p.2, 2016.

E. Rivers, B. Nguyen, S. Havstad, J. Ressler, A. Muzzin et al., Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock, N Engl J Med, vol.345, issue.19, pp.1368-77, 2001.

A. Rhodes, L. E. Evans, W. Alhazzani, M. M. Levy, M. Antonelli et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Crit Care Med. mars, vol.45, issue.3, pp.486-552, 2017.

J. C. Jackson, P. P. Pandharipande, T. D. Girard, N. E. Brummel, J. L. Thompson et al., Depression, Posttraumatic Stress Disorder, and Functional Disability in Survivors of Critical Illness: results from the BRAIN ICU (Bringing to light the Risk Factors And Incidence of Neuropsychological dysfunction in ICU survivors) Investigation: A Longitudinal Cohort Study, Lancet Respir Med. mai, vol.2, issue.5, pp.369-79, 2014.

H. Chua, W. Wong, V. H. Ong, D. Agrawal, A. Vathsala et al., Extended Mortality and Chronic Kidney Disease After Septic Acute Kidney Injury, J Intensive Care Med. 1 juin, vol.35, issue.6, pp.527-562, 2020.

R. Gaci, J. Lemarie, M. Conrad, A. Cravoisy, P. E. Bollaert et al., Early hypertension after vasopressor weaning during septic shock: associated factors and prognostic significance, Minerva Anestesiol, vol.84, issue.2, p.8, 2018.

A. Vieillard-baron, V. Caille, C. Charron, G. Belliard, B. Page et al., Actual incidence of global left ventricular hypokinesia in adult septic shock, Crit Care Med. juin, vol.36, issue.6, pp.1701-1707, 2008.

A. Arfaras-melainis, E. Polyzogopoulou, F. Triposkiadis, A. Xanthopoulos, I. Ikonomidis et al., Heart failure and sepsis: practical recommendations for the optimal management, Heart Fail Rev. 1 mars, vol.25, issue.2, pp.183-94, 2020.

A. C. Gordon, G. D. Perkins, M. Singer, D. F. Mcauley, R. Orme et al., Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis, N Engl J Med, vol.375, issue.17, pp.1638-1686, 2016.

B. Levy, R. Clere-jehl, A. Legras, T. Morichau-beauchant, M. Leone et al., Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction, J Am Coll Cardiol, vol.10, issue.2, pp.173-82, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01858896

O. Hamzaoui, M. Jozwiak, T. Geffriaud, B. Sztrymf, D. Prat et al., Norepinephrine exerts an inotropic effect during the early phase of human septic shock, Br J Anaesth. 1 mars, vol.120, issue.3, pp.517-541, 2018.

C. Chelazzi, G. Villa, P. Mancinelli, D. Gaudio, A. R. Adembri et al., Glycocalyx and sepsis-induced alterations in vascular permeability, Disponible sur, vol.19, 2015.

S. Lambden, Bench to bedside review: therapeutic modulation of nitric oxide in sepsis-an update, Intensive Care Med Exp, vol.2, issue.2019

A. Burgdorff, M. Bucher, and J. Schumann, Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms, J Int Med Res. avr, vol.46, issue.4, pp.1303-1313, 2018.

S. Wei-wei, Y. Yang, S. Yun, and J. Chun, KATP channel action in vascular tone regulation: from genetics to diseases, Sheng Li Xue Bao. 25 févr, vol.64, issue.1, pp.1-13, 2012.

A. Hall, L. W. Busse, and M. Ostermann, Angiotensin in Critical Care, Crit Care. 20 mars, vol.22, issue.1, p.69, 2018.

D. Martineau, S. Lamouche, R. Briand, and N. Yamaguchi, Functional involvement of angiotensin AT2 receptor in adrenal catecholamine secretion in vivo, Can J Physiol Pharmacol. mai, vol.77, issue.5, pp.367-74, 1999.

R. M. Touyz, Oxidative stress and vascular damage in hypertension, Curr Hypertens Rep. févr, vol.2, issue.1, pp.98-105, 2000.

F. Guo, X. Chen, F. Wang, X. Liang, Y. Sun et al., Role of angiotensin II type 1 receptor in angiotensin II-induced cytokine production in macrophages, J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. avr, vol.31, issue.4, pp.351-61, 2011.

T. Mateo, A. Nabah, Y. N. , A. Taha, M. Mata et al., Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines, J Immunol Baltim Md, vol.176, issue.9, pp.5577-86, 1950.

L. Pastore, A. Tessitore, S. Martinotti, E. Toniato, E. Alesse et al., Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo, Circulation, vol.100, issue.15, pp.1646-52, 1999.

J. A. Ferreira and B. D. Bissell, Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock, J Intensive Care Med. févr, vol.33, issue.2, pp.74-86, 2018.

C. Schmidt, B. Kurt, K. Höcherl, and M. Bucher, Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis, Shock Augusta Ga. sept, vol.32, issue.3, pp.239-285, 2009.

M. Bucher, F. Kees, K. Taeger, and A. Kurtz, Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia, Crit Care Med. févr, vol.31, issue.2, pp.566-71, 2003.

L. Donald, W. , L. Howard, R. Gallant-ellen, M. et al., Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock, Circulation. 4 mars, vol.95, issue.5, pp.1122-1127, 1997.

M. Bucher, J. Hobbhahn, K. Taeger, and A. Kurtz, Cytokine-mediated downregulation of vasopressin V1A receptors during acute endotoxemia in rats, Am J Physiol-Regul Integr Comp Physiol. 1 avr, vol.282, issue.4, pp.979-84, 2002.

J. W. Findling, V. O. Waters, and H. Raff, The dissociation of renin and aldosterone during critical illness, J Clin Endocrinol Metab. mars, vol.64, issue.3, pp.592-597, 1987.

D. Du-cheyron, A. Lesage, C. Daubin, M. Ramakers, and P. Charbonneau, Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure, Intensive Care Med, vol.29, issue.10, pp.1703-1712, 2003.

K. C. Doerschug, A. S. Delsing, G. A. Schmidt, and A. Ashare, Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis, Crit Care, vol.14, issue.1, p.24, 2010.

K. S. Chung, J. H. Song, W. J. Jung, Y. S. Kim, S. K. Kim et al., Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock, Korean J Crit Care Med. 31 mai, vol.32, issue.2, pp.142-53, 2017.

R. Bellomo, R. G. Wunderink, H. Szerlip, S. W. English, L. W. Busse et al., Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock, Crit Care, vol.6, issue.2020

A. Khanna, S. W. English, X. S. Wang, K. Ham, J. Tumlin et al., Angiotensin II for the Treatment of Vasodilatory Shock, N Engl J Med. 3 août, vol.377, issue.5, pp.419-449, 2017.

M. Bucher, K. P. Ittner, J. Hobbhahn, K. Taeger, and A. Kurtz, Downregulation of angiotensin II type 1 receptors during sepsis. Hypertens Dallas Tex 1979, août, vol.38, issue.2, pp.177-82, 2001.

C. Schmidt, K. Höcherl, B. Kurt, S. Moritz, A. Kurtz et al., Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock, Cytokine. janv, vol.49, issue.1, pp.30-38, 2010.

K. Mederle, F. Schweda, V. Kattler, E. Doblinger, K. Miyata et al., The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension, Crit Care, vol.17, issue.4, p.130, 2013.

J. Vincent, Y. Sakr, C. L. Sprung, V. M. Ranieri, K. Reinhart et al., Sepsis in European intensive care units: results of the SOAP study, Crit Care Med. févr, vol.34, issue.2, pp.344-53, 2006.

M. Brenner, G. L. Schaer, D. L. Mallory, A. F. Suffredini, and J. E. Parrillo, Detection of Renal Blood Flow Abnormalities in Septic and Critically III Patients Using a Newly Designed Indwelling Thermodilution Renal Vein Catheter, Chest. juill, vol.98, issue.1, pp.170-179, 1990.

J. R. Prowle, M. P. Molan, E. Hornsey, and R. Bellomo, Measurement of renal blood flow by phasecontrast magnetic resonance imaging during septic acute kidney injury: A pilot investigation*, Crit Care Med. juin, vol.40, issue.6, pp.1768-76, 2012.

A. Harrois, N. Grillot, S. Figueiredo, and J. Duranteau, Acute kidney injury is associated with a decrease in cortical renal perfusion during septic shock, Crit Care, vol.15, 2018.

A. G. Schneider, L. Hofmann, G. Wuerzner, N. Glatz, M. Maillard et al., Renal perfusion evaluation with contrast-enhanced ultrasonography, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc. févr, vol.27, issue.2, pp.674-81, 2012.

J. Kosaka, Y. R. Lankadeva, C. N. May, and R. Bellomo, Histopathology of Septic Acute Kidney Injury: A Systematic Review of Experimental Data, Crit Care Med. sept, vol.44, issue.9, pp.897-903, 2016.

A. Aslan, M. C. Van-den-heuvel, C. A. Stegeman, E. R. Popa, A. M. Leliveld et al., Kidney histopathology in lethal human sepsis, Crit Care. 27 déc, vol.22, issue.1, p.359, 2018.

S. Cheng, Y. Chou, F. Liao, C. Lin, C. Liu et al., Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury

R. Rodríguez-romo, K. Benítez, J. Barrera-chimal, R. Pérez-villalva, A. Gómez et al., AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease, Kidney Int. 1 févr, vol.89, issue.2, pp.363-73, 2016.

J. Barrera-chimal, R. Pérez-villalva, R. Rodríguez-romo, J. Reyna, N. Uribe et al., Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury, Kidney Int. 1 janv, vol.83, issue.1, pp.93-103, 2013.

J. Zhang, N. P. Rudemiller, M. B. Patel, Q. Wei, N. S. Karlovich et al., Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI, J Am Soc Nephrol JASN. août, vol.27, issue.8, pp.2257-64, 2016.

K. R. Pechman, D. Miguel, C. Lund, H. Leonard, E. C. Basile et al., Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension, Am J Physiol -Regul Integr Comp Physiol, vol.297, issue.5, pp.1358-63, 2009.

K. R. Spurgeon-pechman, D. L. Donohoe, D. L. Mattson, H. Lund, L. James et al., Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium, Am J Physiol Renal Physiol. juill, vol.293, issue.1, pp.269-278, 2007.

P. Mehrotra, J. B. Patel, C. M. Ivancic, J. A. Collett, and D. P. Basile, Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism, Kidney Int, vol.88, issue.4, pp.776-84, 2015.

K. L. Horne, R. Packington, J. Monaghan, T. Reilly, and N. M. Selby, Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study, Disponible sur, vol.29

C. Hsu, V. M. Chinchilli, S. Coca, P. Devarajan, N. Ghahramani et al., Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study, JAMA Intern Med. 1 mars, vol.180, issue.3, pp.402-412, 2020.

S. Rubin, A. Orieux, B. Clouzeau, C. Rigothier, C. Combe et al., The Incidence of Chronic Kidney Disease Three Years after Non-Severe Acute Kidney Injury in Critically Ill Patients: A Single-Center Cohort Study, Disponible sur, vol.8

C. Hsu, R. K. Hsu, J. Yang, J. D. Ordonez, S. Zheng et al., Elevated BP after AKI, J Am Soc Nephrol JASN. mars, vol.27, issue.3, pp.914-937, 2016.

E. Hessey, S. Perreault, L. Roy, M. Dorais, S. Samuel et al., Acute kidney injury in critically ill children and 5-year hypertension, Pediatr Nephrol Berl Ger. juin, vol.35, issue.6, pp.1097-107, 2020.

. On, . Frog-icu-investigators, E. Gayat, A. Hollinger, A. Cariou et al., Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury, Intensive Care Med. mai, vol.44, issue.5, pp.598-605, 2018.

M. Scarton, A. Oppenheimer, K. Chaïbi, D. Dreyfuss, and S. Gaudry, Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial, Crit Care. déc, vol.23, issue.1, p.148, 2019.

B. Williams, G. Mancia, W. Spiering, A. Rosei, E. Azizi et al., ESC/ESH Guidelines for the management of arterial hypertensionThe Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH), Eur Heart J. 1 sept, vol.39, issue.33, pp.3021-104, 2018.

C. Hsu, K. D. Liu, J. Yang, D. V. Glidden, T. C. Tan et al., Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI, Clin J Am Soc Nephrol, vol.7, issue.2020, pp.26-34

S. Brar, F. Ye, M. T. James, B. Hemmelgarn, S. Klarenbach et al., Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury, JAMA Intern Med. déc, vol.178, issue.12, pp.1681-90, 2018.

A. L. Perrine, C. Lecoffre, J. Blacher, V. Olié, . National et al., AND TEMPORAL TRENDS SINCE, vol.36, p.227, 2006.

D. Levy, Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study, Drugs, vol.35, pp.1-5, 1988.

R. E. Schmieder, M. P. Schlaich, A. U. Klingbeil, and P. Martus, Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc. mars, vol.13, issue.3, pp.564-573, 1996.

B. A. Vakili, P. M. Okin, and R. B. Devereux, Prognostic implications of left ventricular hypertrophy, Am Heart J. mars, vol.141, issue.3, pp.334-375, 2001.

W. Nadruz, A. M. Shah, and S. D. Solomon, Diastolic Dysfunction and Hypertension, Med Clin North Am. janv, vol.101, issue.1, pp.7-17, 2017.

S. K. Gandhi, J. C. Powers, A. M. Nomeir, K. Fowle, D. W. Kitzman et al., The pathogenesis of acute pulmonary edema associated with hypertension, N Engl J Med, vol.344, issue.1, pp.17-22, 2001.

G. Lip, A. Coca, T. Kahan, G. Boriani, A. S. Manolis et al., Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), Cell Electrophysiol Eur Soc Cardiol. 1 juin, vol.19, issue.6, pp.891-911, 2017.

M. J. O'donnell, D. Xavier, L. Liu, H. Zhang, S. L. Chin et al., Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study, Lancet Lond Engl. 10 juill, vol.376, issue.9735, pp.112-135, 2010.

M. F. Elias, P. A. Wolf, D. 'agostino, R. B. Cobb, J. White et al., Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study, Am J Epidemiol. 15 sept, vol.138, issue.6, pp.353-64, 1993.

, The Association Between Midlife Blood Pressure Levels and Late-Life Cognitive Function. The Honolulu-Asia Aging Study -PubMed

C. Hsu, C. E. Mcculloch, J. Darbinian, A. S. Go, and C. Iribarren, Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease, Arch Intern Med. 25 avr, vol.165, issue.8, p.923, 2005.

G. Karen and A. , Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease, Hypertension, vol.70, issue.4, pp.687-94, 2017.

P. K. Christensen, H. P. Hansen, and H. H. Parving, Impaired autoregulation of GFR in hypertensive noninsulin dependent diabetic patients. Kidney Int, vol.52, pp.1369-74, 1997.

P. K. Christensen, E. E. Hommel, P. Clausen, B. Feldt-rasmussen, and H. H. Parving, Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies. Kidney Int, vol.56, pp.1517-1540, 1999.

G. Pinna, C. Pascale, P. Fornengo, S. Arras, C. Piras et al., Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study, PloS One, vol.9, issue.4, p.93542, 2014.

B. Van-den-born, E. C. Löwenberg, N. V. Van-der-hoeven, B. De-laat, J. C. Meijers et al., Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis, J Hypertens. mai, vol.29, issue.5, pp.922-929, 2011.

U. Derhaschnig, C. Testori, E. Riedmueller, S. Aschauer, M. Wolzt et al., Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis, J Hum Hypertens. juin, vol.27, issue.6, pp.368-73, 2013.

S. Rubin, A. Cremer, R. Boulestreau, C. Rigothier, S. Kuntz et al., Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort, J Hypertens, vol.37, issue.2, pp.316-340, 2019.

A. Khwaja, KDIGO clinical practice guidelines for acute kidney injury, Nephron Clin Pract, vol.120, issue.4, pp.179-184, 2012.

U. Derhaschnig, C. Testori, E. Riedmueller, E. L. Hobl, F. B. Mayr et al., Decreased renal function in hypertensive emergencies, J Hum Hypertens. juill, vol.28, issue.7, pp.427-458, 2014.

C. Ince, P. R. Mayeux, T. Nguyen, H. Gomez, J. A. Kellum et al., Shock Augusta Ga. mars, vol.45, issue.3, pp.259-70, 2016.

E. H. Post and J. Vincent, Renal autoregulation and blood pressure management in circulatory shock, Crit Care, vol.22, 2018.

P. E. Marik and R. Rivera, Hypertensive emergencies: an update, Curr Opin Crit Care. déc, vol.17, issue.6, pp.569-80, 2011.

K. Wu, J. Zhou, H. Li, D. Gu, K. Pan et al., Antihypertensive therapy with nicardipine for patients with aortic disease is associated with more esmolol usage than urapidil, J Thorac Dis. déc, vol.6, issue.12, pp.1765-71, 2014.

J. Cotte, D. Aranda, E. Esnault, P. Bordes, J. Meaudre et al.,

, Rev Pneumol Clin. juin, vol.68, issue.3, pp.221-225, 2012.

K. Nakazawa and K. Amaha, Effect of nicardipine hydrochloride on regional hypoxic pulmonary vasoconstriction, Br J Anaesth. avr, vol.60, issue.5, pp.547-54, 1988.

A. Mishra, R. M. Reed, M. Eberlein, and . Severe, Rapidly Reversible Hypoxemia in the Early Period after Bilateral Lung Transplantation, vol.13, pp.979-85, 2016.

F. I. Kvam, J. Ofstad, and B. M. Iversen, Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR, Am J Physiol, vol.275, issue.4, pp.576-584, 1998.

C. Bopp, C. Auger, A. Mebazaa, G. P. Joshi, V. B. Schini-kerth et al., Urapidil, but not dihydropyridine calcium channel inhibitors, preserves the hypoxic pulmonary vasoconstriction: an experimental study in pig arteries, Fundam Clin Pharmacol, vol.33, issue.5, pp.527-561, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02322364

J. Shi, Y. Li, C. Xing, P. Peng, H. Shi et al., compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis, Drug Des Devel Ther, vol.13, pp.161-72, 2019.

Y. Zhou-y-j, Q. J. Fu-y, T. S. , and C. , Therapeutic effects of intravenous urapidil in elderly patients with hypertension and acute decompensated heart failure: A pilot clinical trial, Exp Ther Med. juill, vol.12, issue.1, pp.115-137, 2016.

W. F. Peacock, D. E. Hilleman, P. D. Levy, D. H. Rhoney, and J. Varon, A systematic review of nicardipine vs labetalol for the management of hypertensive crises, Am J Emerg Med. juill, vol.30, issue.6, pp.981-93, 2012.

H. C. Prescott and D. C. Angus, Enhancing Recovery From Sepsis: A Review, JAMA, vol.319, issue.1, pp.62-75, 2018.

M. Wu, P. Tsou, Y. Wang, M. Lee, C. Chao et al., Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study, Crit Care Lond Engl. 2 sept, vol.23, issue.1, p.293, 2019.

S. Ou, H. Chu, P. Chao, Y. Lee, S. Kuo et al., Long-Term Mortality and Major Adverse Cardiovascular Events in Sepsis Survivors. A Nationwide Population-based Study, Am J Respir Crit Care Med, vol.15, issue.2, pp.209-226, 2016.

A. J. Peixoto, Acute Severe Hypertension. Solomon CG, éditeur, N Engl J Med, vol.381, pp.1843-52, 2019.

P. M. Palevsky, B. A. Molitoris, M. D. Okusa, A. Levin, S. S. Waikar et al., Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology, Clin J Am Soc Nephrol. 1 mai, vol.7, issue.5, pp.844-50, 2012.

M. W. Semler, T. W. Rice, A. D. Shaw, E. D. Siew, W. H. Self et al., Identification of Major Adverse Kidney Events Within the Electronic Health Record, J Med Syst. juill, vol.40, issue.7, p.167, 2016.

B. Van-den-born, G. Lip, J. Brguljan-hitij, A. Cremer, J. Segura et al., ESC Council on hypertension position document on the management of hypertensive emergencies, Eur Heart J Cardiovasc Pharmacother, vol.01, issue.1, pp.37-46, 2019.

D. Ettehad, C. A. Emdin, A. Kiran, S. G. Anderson, T. Callender et al., Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis, The Lancet. mars, vol.387, pp.957-67, 2016.

A. Définitions,

, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Reçu à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, que je sois déshonoré et méprisé si j'y manque